ATE99931T1 - Inhibitoren fuer zellenzuwachs und methoden fuer krebsbehandlung. - Google Patents

Inhibitoren fuer zellenzuwachs und methoden fuer krebsbehandlung.

Info

Publication number
ATE99931T1
ATE99931T1 AT88908058T AT88908058T ATE99931T1 AT E99931 T1 ATE99931 T1 AT E99931T1 AT 88908058 T AT88908058 T AT 88908058T AT 88908058 T AT88908058 T AT 88908058T AT E99931 T1 ATE99931 T1 AT E99931T1
Authority
AT
Austria
Prior art keywords
cell growth
methods
cancer treatment
growth inhibitors
inhibitors
Prior art date
Application number
AT88908058T
Other languages
English (en)
Inventor
Barry M Markaverich
James H Clark
Rebecca Gregory
Mary Alejandro
Brian S Middleditch
Gregory A Johnson
Rajender Singh Varma
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Application granted granted Critical
Publication of ATE99931T1 publication Critical patent/ATE99931T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88908058T 1987-07-28 1988-07-20 Inhibitoren fuer zellenzuwachs und methoden fuer krebsbehandlung. ATE99931T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7919987A 1987-07-28 1987-07-28
EP88908058A EP0374184B1 (de) 1987-07-28 1988-07-20 Inhibitoren für zellenzuwachs und methoden für krebsbehandlung
PCT/US1988/002476 WO1989000849A1 (en) 1987-07-28 1988-07-20 Cell growth inhibitors and methods of treating cancer and cell proliferative diseases

Publications (1)

Publication Number Publication Date
ATE99931T1 true ATE99931T1 (de) 1994-01-15

Family

ID=22149049

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88908058T ATE99931T1 (de) 1987-07-28 1988-07-20 Inhibitoren fuer zellenzuwachs und methoden fuer krebsbehandlung.

Country Status (8)

Country Link
US (1) US5216024A (de)
EP (1) EP0374184B1 (de)
JP (1) JPH03501249A (de)
AT (1) ATE99931T1 (de)
AU (1) AU625313B2 (de)
CA (1) CA1332742C (de)
DE (1) DE3887151T2 (de)
WO (1) WO1989000849A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698225A (en) * 1985-04-15 1987-10-06 Morrison David G Granular binding agent for pellets
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
WO1994026303A1 (en) * 1993-05-13 1994-11-24 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
IL112205A0 (en) * 1994-01-06 1995-03-15 Res Dev Foundation Curcumin, analogues of curcumin and novel uses thereof
JPH10505348A (ja) 1994-08-31 1998-05-26 イーライ・リリー・アンド・カンパニー 耐性腫瘍の同定および治療方法
US5710179A (en) * 1995-04-05 1998-01-20 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Antitumor agent
US7611533B2 (en) 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
AU713863B2 (en) * 1995-06-19 1999-12-09 Ontogen Corporation Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
GB0505509D0 (en) * 2005-03-17 2005-04-27 Ic Innovations Ltd Compounds
WO2007026875A1 (ja) * 2005-09-02 2007-03-08 Ube Industries, Ltd. 光学活性（Ｓ又はＲ）－α－ヒドロキシ酸及び光学活性（Ｒ又はＳ）－α－ヒドロキシ酸エステルの製造方法
DK2061452T3 (da) * 2006-09-01 2012-02-13 Piramal Life Sciences Ltd Anvendelse af koffeinsyre og derivater deraf mod cancer
CN102697757B (zh) * 2012-05-18 2014-06-04 广州军区广州总医院 对羟基苄叉丙酮在制备预防和/或治疗脑病药物中的应用
CN113480418B (zh) * 2021-07-13 2022-09-06 上海健康医学院 一种化合物，及其在制备治疗癌症药物方面的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2451149A (en) * 1942-11-16 1948-10-12 Nipa Lab Ltd Manufacture of materials resistant to or active against microorganisms
GB1438652A (en) * 1972-07-19 1976-06-09 Shell Int Research Hydroxyl phenyl-substituted ketones and their preparation
US4124724A (en) * 1975-12-08 1978-11-07 Agoro John W Crystalline caffeic acid derivatives and compositions and method for treating snakebite
NL7804290A (nl) * 1977-05-12 1978-11-14 Henkel Kgaa Ontsteking vertragend middel voor cosmetische prepara- ten.
GB1591063A (en) * 1977-07-11 1981-06-10 Ici Ltd Monoalkylation of dihydroxybenzenes
JPS54160740A (en) * 1978-06-09 1979-12-19 Takeda Chem Ind Ltd Anti-fibrotic agent
US4219569A (en) * 1978-10-10 1980-08-26 The Upjohn Company Process for treating inflammation
FR2481270A1 (fr) * 1980-04-24 1981-10-30 Roussel Uclaf Nouveaux derives substitues de l'acide 4-phenyl 4-oxo 2-hydroxy butanoique, procede pour leur preparation et applications comme medicaments
IT1171604B (it) * 1981-10-22 1987-06-10 Roussel Maestretti Spa Derivati di acido 4-fenil-4-ossobuten-2-oico dotati di proprieta' farmacologiche e loro procedimento di preparazione
DE3150233A1 (de) * 1981-12-18 1983-06-30 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2-(hydroxiphenoxi)-carbonsaeureestern
JPS59104340A (ja) * 1982-12-07 1984-06-16 Ube Ind Ltd ベンジルアセトン類の製造方法
GB2141626B (en) * 1983-04-25 1987-01-28 Kao Corp Cinnamic acid derivatives for lightening melanin pigmentation of skin
JPS60222437A (ja) * 1984-04-17 1985-11-07 Ube Ind Ltd １−フエニル−２−アルカノン類の製造法
JPS60248645A (ja) * 1984-05-23 1985-12-09 Green Cross Corp:The カフエ−酸誘導体
EP0464859A1 (de) * 1984-05-23 1992-01-08 Green Cross Corporation Hemmstoff von Lipoxygenase
JPH0623130B2 (ja) * 1984-07-10 1994-03-30 三井東圧化学株式会社 α−ケト酸の製造方法
IT1190340B (it) * 1986-06-06 1988-02-16 Roussel Maestretti Spa Derivati dell'acido 4-fenil 4-osso 2-butenoico,loro procedimento di preparazione e loro impiego come prodotti medicinali
AU601992B2 (en) * 1986-06-21 1990-09-27 Dainippon Ink And Chemicals Inc. Isoliquiritigenin for the treatment of kidney and liver diseases

Also Published As

Publication number Publication date
EP0374184A1 (de) 1990-06-27
DE3887151T2 (de) 1994-06-30
JPH03501249A (ja) 1991-03-22
CA1332742C (en) 1994-10-25
US5216024A (en) 1993-06-01
DE3887151D1 (de) 1994-02-24
AU2315288A (en) 1989-03-01
AU625313B2 (en) 1992-07-09
EP0374184B1 (de) 1994-01-12
WO1989000849A1 (en) 1989-02-09

Similar Documents

Publication Publication Date Title
ATE99931T1 (de) Inhibitoren fuer zellenzuwachs und methoden fuer krebsbehandlung.
ES452695A1 (es) Un procedimiento para la preparacion de compuestos de 2-fe- nil-3-aroilbenzotiofeno.
DE3850026D1 (de) Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren.
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
TR200200068T2 (tr) Nematisital triflüorobütenler
NO20003600D0 (no) Kaliumkanal inhibitorer
ES2032376T3 (es) Procedimiento para preparar 2-sustituidos-(amino-sustituidos)-n-arilalquil-3-(indol-3-il)propanimidas.
ES2040208T3 (es) Pirazolinas insecticidas.
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
PL285248A1 (en) Method of obtaining novel aminophenol derivatives
ES452737A1 (es) Un procedimiento para preparar compuestos 2-anol-3-fenilben-zotiofeno.
ATE300541T1 (de) Pyrazolopyridinderivate
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
AU5317279A (en) Hydroxypropyl-triazole derivatives and their use as antimycotic agents
ATE128128T1 (de) Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.
PT1212311E (pt) Cumarinas de calcona
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
PT977716E (pt) Utilizacao de alcoois como aditivos para rebocos e/ou argamassas
IT7827273A0 (it) Procedimento per il trattamento superficiale stabilizzante di corpi semiconduttori.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
ES491960A0 (es) Procedimiento para la obtencion de derivados de sisomicina
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
ES479059A1 (es) Procedimiento para preparar derivados del naftaleno.
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
DK162440C (da) Pyrazindiazohydroxidforbindelser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties